The summary below was generated by an AI language model and may contain errors or omissions. All other content on this page is deterministically extracted from the original SEC EDGAR filing.
Amgen maintained its overall risk factor structure between the 2023 and 2024 10-K filings, with no new risks added and no existing risks removed. Two risk categories underwent substantive modifications: "Risks Related to Economic Conditions and Operating a Global Business" and "General Risk Factors," indicating Amgen refined its disclosure of existing risk exposures rather than identifying entirely new categories of concern.
Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.
Historical year-over-year comparisons (2024 vs 2023 and earlier) are available on the Pro plan.
Get full access — from $29/month Already a Pro subscriber? View full diff →